MaxCyte, Inc. (LON:MXCT – Get Free Report) insider Stan Erck sold 47,689 shares of MaxCyte stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of GBX 388 ($5.19), for a total value of £185,033.32 ($247,503.10).
MaxCyte Stock Performance
Shares of MXCT opened at GBX 280 ($3.75) on Friday. MaxCyte, Inc. has a 52-week low of GBX 180 ($2.41) and a 52-week high of GBX 430 ($5.75). The stock’s 50-day simple moving average is GBX 316.07 and its 200 day simple moving average is GBX 332.58. The company has a debt-to-equity ratio of 8.37, a quick ratio of 14.38 and a current ratio of 14.31. The stock has a market capitalization of £294.25 million, a price-to-earnings ratio of -1,120.00 and a beta of 1.13.
MaxCyte Company Profile
Featured Stories
- Five stocks we like better than MaxCyte
- What is the Nikkei 225 index?
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- What Do S&P 500 Stocks Tell Investors About the Market?
- MarketBeat Week in Review – 9/30 – 10/4
- How to Calculate Inflation Rate
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.